The largest database of trusted experimental protocols

Soluplus

Manufactured by Ashland
Sourced in United States

Soluplus® is a polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer developed by Ashland. It is a multifunctional polymer that can be used as a solubilizer, binder, and matrix former in various pharmaceutical applications.

Automatically generated - may contain errors

3 protocols using soluplus

1

Amorphous Drug Crystallization Behavior

Check if the same lab product or an alternative is used in the 5 most similar protocols
Griseofulvin (GRI) (Ph. Eur. grade) was purchased from Fagron (Rotterdam, The Netherlands), and itraconazole (ITR) (Ph. Eur. grade) was purchased from Ria International India (Madurai, India). GRI and ITR belong to crystallization tendency class 1 and class 3, respectively [25 (link)]. This means that amorphous GRI crystallized in a DSC experiment during cooling before reaching the glass-transition temperature. In contrast, amorphous ITR neither crystallized during cooling below the glass-transition temperature nor during subsequent reheating to the melting point [25 (link)]. The polymers PVPVA (Plasdone S-630) with a molecular weight of 40,000 and Soluplus® with a molecular weight of 118,000 g/mol were obtained from Ashland Inc. (Wilmington, DE, USA) and BASF (Ludwigshafen, Germany), respectively. Dichloromethane (purity > 98%) was purchased from VWR (Randor, PA, USA). All substances were used without further purification. Water used for long-term stability tests was filtered and deionized with a Merck Millipore purification system (Darmstadt, Germany). Figure 1 shows the chemical structures of the investigated compounds GRI, ITR, Soluplus®, and PVPVA.
+ Open protocol
+ Expand
2

Amorphous Solid Dispersions of Griseofulvin

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASDs were prepared by spray drying and treated by secondary drying to remove residual solvent. PVPVA (Plasdone S-630) and Soluplus® were used as polymers and were obtained from Ashland Inc. (Columbus, USA) and BASF SE (Ludwigshafen, Germany), respectively. Griseofulvin (GRI) (Ph. Eur. Grade) was investigated as model API and was purchased from Fagron (Rotterdam, Netherlands). Dichloromethane (purity >98%) served as solvent in the spray-drying process and was purchased from VWR (Randor, USA). All substances were used without further purification.
Crystallinity measurements were performed using water-sorption measurements and Raman measurements. Filtered and deionized water (Merck Millipore purification system, Darmstadt, Germany) was used for generating water vapor in the DVS/crystallinity measurements and shelf life tests. A detailed description of the applied methods is provided in part 1 of this paper series (Wolbert et al., 2022a (link)).
+ Open protocol
+ Expand
3

Transdermal delivery of NAR

Check if the same lab product or an alternative is used in the 5 most similar protocols
NAR ((2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one, purity ≥ 98%, lot MKCD1056) was obtained from Sigma-Aldrich (St. Louis, MO, USA). The polymer Parteck® MXP (PVA, polyvinyl alcohol, lot F1952064) was donated by Merck (Darmstadt, Germany). KlucelTM EF (HPC, hydroxypropylcellulose, lot 40915) and Soluplus® (SOL, polyvinyl-caprolactam-polyvinyl-acetate-polyethyleneglycol, lot 844143368EO) were donated by Ashland Specialty Ingredients (Covington, LA, USA) and BASF (Ludwigshafen, Germany), respectively. Glycerin (GLY, lot 58591) and Tween 80 (polysorbate, lot 105896) were obtained from Dinâmica® (Sao Paulo, Brazil). Skin from porcine ears was obtained from a local slaughterhouse (Via Carnes Indústria e Comércio, Brasilia, Brazil). The whole skin was removed from the outer region of the ear, separated from its underlying layer, and used full thickness.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!